Jorn Drappa - Feb 4, 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Chief Medical Officer
Signature: /s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol: VTYX
Transactions as of: Feb 4, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/4/2022, 05:38 PM
Previous filing: Oct 20, 2021
Next filing: Jul 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTYX	Stock Option (right to buy)	Award	$0	+145K		$0.00	145K	Feb 4, 2022	Common Stock	145K	$12.21	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 3, 2022.

Content

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 3, 2022.